HUMOG

This brand name is authorized in Nigeria.

Active ingredients

The drug HUMOG contains one active pharmaceutical ingredient (API):

1
UNII 5Y9QQM372Q - MENOTROPINS
 
Read more about Menotropin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A6-0232 Powder for injection Humog 75 HP INJ_PWD 75 IU 1 x 1's (in vial) + 1 mL Sodium Chloride Injection BP as solvent (in ampoule) Freeze dried powder for Injection in a vial plus 1 mL Sodium Chloride Injection BP as solvent (in ampoule). White powder or cake 18/12/2024
A6-0233 Powder for injection Humog 150 HP Injection INJ_PWD 150 IU 1 x 1's (in vial) + 1 mL Sodium Chloride Injection BP as solvent (in ampoule) Freeze dried powder for Injection in a vial plus 1 mL of Sodium Chloride Injection BP as diluent in an ampoule. White powder or cake 18/12/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G03GA02 Human menopausal gonadotrophin G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A6-0232, A6-0233

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.